[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Europe Oncology Biosimilars Market Report 2016

September 2016 | 123 pages | ID: E8DEA89C637EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Oncology Biosimilars

Revenue, means the sales value of Oncology Biosimilars

This report studies sales (consumption) of Oncology Biosimilars in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • Covidien llc (Medtronic)
  • Johnson & Johnson MEDICAL
  • Bolton Surgical
  • Platts & Nisbett
  • Frankenman International
  • Changzhou Waston
  • Jiangsu Qianjing Medical
  • Changzhou Anker Medical
  • Changzhou Tongchuang Medical
  • Jiangsu Reable Medical
  • Changzhou Resource Medical
  • Jiangsu Kangjin Medical
  • Pfizer
  • Wockhardt
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Oncology Biosimilars in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on sales, market share and growth rate of Oncology Biosimilars in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Europe Oncology Biosimilars Market Report 2016

1 ONCOLOGY BIOSIMILARS OVERVIEW

1.1 Product Overview and Scope of Oncology Biosimilars
1.2 Classification of Oncology Biosimilars
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Oncology Biosimilars
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Oncology Biosimilars Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Oncology Biosimilars (2011-2021)
  1.5.1 Europe Oncology Biosimilars Sales and Growth Rate (2011-2021)
  1.5.2 Europe Oncology Biosimilars Revenue and Growth Rate (2011-2021)

2 EUROPE ONCOLOGY BIOSIMILARS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Oncology Biosimilars Market Competition by Manufacturers
  2.1.1 Europe Oncology Biosimilars Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Oncology Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Oncology Biosimilars (Volume and Value) by Type
  2.2.1 Europe Oncology Biosimilars Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Oncology Biosimilars Revenue and Market Share by Type (2011-2016)
2.3 Europe Oncology Biosimilars (Volume and Value) by Countries
  2.3.1 Europe Oncology Biosimilars Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Oncology Biosimilars Revenue and Market Share by Countries (2011-2016)
2.4 Europe Oncology Biosimilars (Volume) by Application

3 GERMANY ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Oncology Biosimilars Sales and Value (2011-2016)
  3.1.1 Germany Oncology Biosimilars Sales and Growth Rate (2011-2016)
  3.1.2 Germany Oncology Biosimilars Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Oncology Biosimilars Sales Price Trend (2011-2016)
3.2 Germany Oncology Biosimilars Sales and Market Share by Manufacturers
3.3 Germany Oncology Biosimilars Sales and Market Share by Type
3.4 Germany Oncology Biosimilars Sales and Market Share by Application

4 FRANCE ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

4.1 France Oncology Biosimilars Sales and Value (2011-2016)
  4.1.1 France Oncology Biosimilars Sales and Growth Rate (2011-2016)
  4.1.2 France Oncology Biosimilars Revenue and Growth Rate (2011-2016)
  4.1.4 France Oncology Biosimilars Sales Price Trend (2011-2016)
4.2 France Oncology Biosimilars Sales and Market Share by Manufacturers
4.3 France Oncology Biosimilars Sales and Market Share by Type
4.4 France Oncology Biosimilars Sales and Market Share by Application

5 UK ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Oncology Biosimilars Sales and Value (2011-2016)
  5.1.1 UK Oncology Biosimilars Sales and Growth Rate (2011-2016)
  5.1.2 UK Oncology Biosimilars Revenue and Growth Rate (2011-2016)
  5.1.5 UK Oncology Biosimilars Sales Price Trend (2011-2016)
5.2 UK Oncology Biosimilars Sales and Market Share by Manufacturers
5.3 UK Oncology Biosimilars Sales and Market Share by Type
5.4 UK Oncology Biosimilars Sales and Market Share by Application

6 RUSSIA ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Oncology Biosimilars Sales and Value (2011-2016)
  6.1.1 Russia Oncology Biosimilars Sales and Growth Rate (2011-2016)
  6.1.2 Russia Oncology Biosimilars Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Oncology Biosimilars Sales Price Trend (2011-2016)
6.2 Russia Oncology Biosimilars Sales and Market Share by Manufacturers
6.3 Russia Oncology Biosimilars Sales and Market Share by Type
6.4 Russia Oncology Biosimilars Sales and Market Share by Application

7 ITALY ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Oncology Biosimilars Sales and Value (2011-2016)
  7.1.1 Italy Oncology Biosimilars Sales and Growth Rate (2011-2016)
  7.1.2 Italy Oncology Biosimilars Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Oncology Biosimilars Sales Price Trend (2011-2016)
7.2 Italy Oncology Biosimilars Sales and Market Share by Manufacturers
7.3 Italy Oncology Biosimilars Sales and Market Share by Type
7.4 Italy Oncology Biosimilars Sales and Market Share by Application

8 SPAIN ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Oncology Biosimilars Sales and Value (2011-2016)
  8.1.1 Spain Oncology Biosimilars Sales and Growth Rate (2011-2016)
  8.1.2 Spain Oncology Biosimilars Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Oncology Biosimilars Sales Price Trend (2011-2016)
8.2 Spain Oncology Biosimilars Sales and Market Share by Manufacturers
8.3 Spain Oncology Biosimilars Sales and Market Share by Type
8.4 Spain Oncology Biosimilars Sales and Market Share by Application

9 BENELUX ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Oncology Biosimilars Sales and Value (2011-2016)
  9.1.1 Benelux Oncology Biosimilars Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Oncology Biosimilars Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Oncology Biosimilars Sales Price Trend (2011-2016)
9.2 Benelux Oncology Biosimilars Sales and Market Share by Manufacturers
9.3 Benelux Oncology Biosimilars Sales and Market Share by Type
9.4 Benelux Oncology Biosimilars Sales and Market Share by Application

10 EUROPE ONCOLOGY BIOSIMILARS MANUFACTURERS ANALYSIS

10.1 Covidien llc (Medtronic)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Oncology Biosimilars Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Covidien llc (Medtronic) Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Johnson & Johnson MEDICAL
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Oncology Biosimilars Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Johnson & Johnson MEDICAL Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Bolton Surgical
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Oncology Biosimilars Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Bolton Surgical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Platts & Nisbett
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Oncology Biosimilars Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Platts & Nisbett Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Frankenman International
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Oncology Biosimilars Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Frankenman International Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Changzhou Waston
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Oncology Biosimilars Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Changzhou Waston Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Jiangsu Qianjing Medical
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Oncology Biosimilars Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Jiangsu Qianjing Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Changzhou Anker Medical
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Oncology Biosimilars Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Changzhou Anker Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Changzhou Tongchuang Medical
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Oncology Biosimilars Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Changzhou Tongchuang Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Jiangsu Reable Medical
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Oncology Biosimilars Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Jiangsu Reable Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Changzhou Resource Medical
10.12 Jiangsu Kangjin Medical
10.13 Pfizer
10.14 Wockhardt

11 ONCOLOGY BIOSIMILARS MANUFACTURING COST ANALYSIS

11.1 Oncology Biosimilars Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Oncology Biosimilars

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Oncology Biosimilars Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE ONCOLOGY BIOSIMILARS MARKET FORECAST (2016-2021)

14.1 Germany Oncology Biosimilars Sales Forecast (2016-2021)
14.2 France Oncology Biosimilars Sales Forecast (2016-2021)
14.3 UK Oncology Biosimilars Sales Forecast (2016-2021)
14.4 Russia Oncology Biosimilars Sales Forecast (2016-2021)
14.5 Italy Oncology Biosimilars Sales Forecast (2016-2021)
14.6 Spain Oncology Biosimilars Sales Forecast (2016-2021)
14.7 Benelux Oncology Biosimilars Sales Forecast (2016-2021)
14.8 Europe Oncology Biosimilars Sales Forecast by Type (2016-2021)
14.9 Europe Oncology Biosimilars Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Oncology Biosimilars
Table Classification of Oncology Biosimilars
Figure Europe Sales Market Share of Oncology Biosimilars by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Oncology Biosimilars
Figure Europe Sales Market Share of Oncology Biosimilars by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure France Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure UK Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Russia Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Italy Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Spain Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Benelux Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Europe Oncology Biosimilars Sales and Growth Rate (2011-2021)
Figure Europe Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Table Europe Oncology Biosimilars Sales of Key Manufacturers (2015 and 2016)
Table Europe Oncology Biosimilars Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Oncology Biosimilars Sales Share by Manufacturers
Figure 2016 Oncology Biosimilars Sales Share by Manufacturers
Table Europe Oncology Biosimilars Revenue by Manufacturers (2015 and 2016)
Table Europe Oncology Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Oncology Biosimilars Revenue Share by Manufacturers
Table 2016 Europe Oncology Biosimilars Revenue Share by Manufacturers
Table Europe Oncology Biosimilars Sales and Market Share by Type (2011-2016)
Table Europe Oncology Biosimilars Sales Share by Type (2011-2016)
Figure Sales Market Share of Oncology Biosimilars by Type (2011-2016)
Figure Europe Oncology Biosimilars Sales Growth Rate by Type (2011-2016)
Table Europe Oncology Biosimilars Revenue and Market Share by Type (2011-2016)
Table Europe Oncology Biosimilars Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Oncology Biosimilars by Type (2011-2016)
Figure Europe Oncology Biosimilars Revenue Growth Rate by Type (2011-2016)
Table Europe Oncology Biosimilars Sales and Market Share by Countries (2011-2016)
Table Europe Oncology Biosimilars Sales Share by Countries (2011-2016)
Figure Sales Market Share of Oncology Biosimilars by Countries (2011-2016)
Table Europe Oncology Biosimilars Revenue and Market Share by Countries (2011-2016)
Table Europe Oncology Biosimilars Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Oncology Biosimilars by Countries (2011-2016)
Table Europe Oncology Biosimilars Sales and Market Share by Application (2011-2016)
Table Europe Oncology Biosimilars Sales Share by Application (2011-2016)
Figure Sales Market Share of Oncology Biosimilars by Application (2011-2016)
Figure Germany Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Germany Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Germany Oncology Biosimilars Sales Price Trend (2011-2016)
Table Germany Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Germany Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Germany Oncology Biosimilars Sales by Type (2015 and 2016)
Table Germany Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Germany Oncology Biosimilars Sales by Application (2015 and 2016)
Table Germany Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure France Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure France Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure France Oncology Biosimilars Sales Price Trend (2011-2016)
Table France Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table France Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table France Oncology Biosimilars Sales by Type (2015 and 2016)
Table France Oncology Biosimilars Market Share by Type (2015 and 2016)
Table France Oncology Biosimilars Sales by Application (2015 and 2016)
Table France Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure UK Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure UK Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure UK Oncology Biosimilars Sales Price Trend (2011-2016)
Table UK Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table UK Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table UK Oncology Biosimilars Sales by Type (2015 and 2016)
Table UK Oncology Biosimilars Market Share by Type (2015 and 2016)
Table UK Oncology Biosimilars Sales by Application (2015 and 2016)
Table UK Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure Russia Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Russia Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Russia Oncology Biosimilars Sales Price Trend (2011-2016)
Table Russia Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Russia Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Russia Oncology Biosimilars Sales by Type (2015 and 2016)
Table Russia Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Russia Oncology Biosimilars Sales by Application (2015 and 2016)
Table Russia Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure Italy Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Italy Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Italy Oncology Biosimilars Sales Price Trend (2011-2016)
Table Italy Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Italy Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Italy Oncology Biosimilars Sales by Type (2015 and 2016)
Table Italy Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Italy Oncology Biosimilars Sales by Application (2015 and 2016)
Table Italy Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure Spain Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Spain Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Spain Oncology Biosimilars Sales Price Trend (2011-2016)
Table Spain Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Spain Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Spain Oncology Biosimilars Sales by Type (2015 and 2016)
Table Spain Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Spain Oncology Biosimilars Sales by Application (2015 and 2016)
Table Spain Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure Benelux Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Benelux Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Benelux Oncology Biosimilars Sales Price Trend (2011-2016)
Table Benelux Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Benelux Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Benelux Oncology Biosimilars Sales by Type (2015 and 2016)
Table Benelux Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Benelux Oncology Biosimilars Sales by Application (2015 and 2016)
Table Benelux Oncology Biosimilars Market Share by Application (2015 and 2016)
Table Oncology Biosimilars Basic Information List
Table Covidien llc (Medtronic) Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Covidien llc (Medtronic) Oncology Biosimilars Sales Market Share (2011-2016)
Table Johnson & Johnson MEDICAL Basic Information List
Table Johnson & Johnson MEDICAL Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson MEDICAL Oncology Biosimilars Sales Market Share (2011-2016)
Table Bolton Surgical Basic Information List
Table Bolton Surgical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bolton Surgical Oncology Biosimilars Sales Market Share (2011-2016)
Table Platts & Nisbett Basic Information List
Table Platts & Nisbett Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Platts & Nisbett Oncology Biosimilars Sales Market Share (2011-2016)
Table Frankenman International Basic Information List
Table Frankenman International Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Frankenman International Oncology Biosimilars Sales Market Share (2011-2016)
Table Changzhou Waston Basic Information List
Table Changzhou Waston Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Waston Oncology Biosimilars Sales Market Share (2011-2016)
Table Jiangsu Qianjing Medical Basic Information List
Table Jiangsu Qianjing Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jiangsu Qianjing Medical Oncology Biosimilars Sales Market Share (2011-2016)
Table Changzhou Anker Medical Basic Information List
Table Changzhou Anker Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Anker Medical Oncology Biosimilars Sales Market Share (2011-2016)
Table Changzhou Tongchuang Medical Basic Information List
Table Changzhou Tongchuang Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Tongchuang Medical Oncology Biosimilars Sales Market Share (2011-2016)
Table Jiangsu Reable Medical Basic Information List
Table Jiangsu Reable Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jiangsu Reable Medical Oncology Biosimilars Sales Market Share (2011-2016)
Table Changzhou Resource Medical Basic Information List
Table Changzhou Resource Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Resource Medical Oncology Biosimilars Sales Market Share (2011-2016)
Table Jiangsu Kangjin Medical Basic Information List
Table Jiangsu Kangjin Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jiangsu Kangjin Medical Oncology Biosimilars Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Oncology Biosimilars Sales Market Share (2011-2016)
Table Wockhardt Basic Information List
Table Wockhardt Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Wockhardt Oncology Biosimilars Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Biosimilars
Figure Manufacturing Process Analysis of Oncology Biosimilars
Figure Oncology Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
Table Major Buyers of Oncology Biosimilars
Table Distributors/Traders List
Figure Germany Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Germany Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure France Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure France Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure UK Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure UK Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Russia Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Italy Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Spain Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Table Europe Oncology Biosimilars Sales Forecast by Type (2016-2021)
Table Europe Oncology Biosimilars Sales Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories